Heart failure. ([2017])

• Record Type: Book
• Further Information: Note: Johann Bauersachs, Javed Butler, Peter Sandner, editors.
• Editors: Bauersachs, Johann; Butler, Javed; Sandner, Peter
• Contents: The three-decade long journey in heart failure drug development / Kelly S. Lewis, Javed Butler, Johann Bauersachs, Peter Sandner -- Epidemiology of heart failure / Francesco Orso, Gianna Fabbri, Aldo Pietro Maggioni -- Comorbidities in heart failure / Haye H. van der Wal, Vincent M. van Deursen, Peter van der Meer, Adriaan A. Voors -- Clinical trial design, endpoints, and regulatory requirements / Giuseppe M.C. Rosano -- Biomarkers of heart failure with preserved and reduced ejection fraction / Michele Senni, Emilia D'Elia, Michele Emdin, Giuseppe Vergaro -- Heart failure guidelines on pharmacotherapy / Lampros Papadimitriou, Carine E. Hamo, Javed Butler -- Sacubitril/valsartan (LCZ696) in heart failure / Yasser Khder, Victor Shi, John J.V. McMurray, Martin P. Lefkowitz -- Ivabradine / Michel Komajda -- Partial adenosine A1 agonist in heart failure / Wilfried Dinh, Barbara Albrecht-Küpper, Mihai Gheorghiade, Adriaan A. Voors [and others] -- New and emerging therapies and targets: beta-3 agonists / Lauriane Y.M. Michel, Jean-Luc Balligand -- Novel SGC stimulators and SGC activators for the treatment of heart failure / Stefanie Breitenstein, Lothar Roessig, Peter Sandner, Kelly S. Lewis -- Cardiac phosphodiesterases and their modulation for treating heart disease / Grace E. Kim PhD, David A. Kass MD -- Steroidal and novel non-steroidal mineralocorticoid receptor antagonists in heart failure and cardiorenal diseases: comparison at bench and bedside / Peter Kolkhof, Frederic Jaisser, So-Young Kim, Gerasimos Filippatos, Christina Nowack [and others] -- Vasopressin and vasopressin antagonists in heart failure / Julie K. Vishram-Nielsen, Finn Gustafsson -- Mesenchymal stem cell therapy for the treatment of heart failure caused by ischemic or non-ischemic cardiomyopathy: immunosuppression and its implications / Michael J. Lipinski, Dror Luger, Stephen E. Epstein -- Platelet-derived growth factor in heart failure / John Medamana, Richard A. Clark, Javed Butler -- Wnt signaling in cardiac remodeling and heart failure / Vasili Stylianidis, Kevin C.M. Hermans, W. Matthijs Blankesteijn -- Gene therapy in heart failure / Anthony S. Fargnoli, Michael G. Katz, Charles R. Bridges, Roger J. Hajjar -- Noncoding RNAs in heart failure / Seema Dangwal, Katharina Schimmel, Ariana Foinquinos, Ke Xiao, Thomas Thum -- Cardiac myosin activation with gene therapy produces sustained inotropic effects and may treat heart failure with reduced ejection fraction / Sam L. Teichman, Kassandra S. Thomson, Michael Regnier.
• Publisher Details: Cham, Switzerland : Springer
• Publication Date: 2017
• Copyright Date: 2017
• Extent: 1 online resource (ix, 581 pages), illustrations (some color)
• Subjects: 616.1/2; Medicine; Heart failure; Toxicology; Cardiology; Human physiology; HEALTH & FITNESS -- Diseases -- General; MEDICAL -- Clinical Medicine; MEDICAL -- Diseases; MEDICAL -- Evidence-Based Medicine; MEDICAL -- Internal Medicine; Heart failure; Medical -- Cardiology; Medical -- Physiology; Cardiovascular medicine; Physiology; Medical -- Pharmacology; Pharmacology; Heart Failure -- therapy; Electronic books
• Languages: English
• ISBNs: 9783319596594; 3319596594
• Related ISBNs: 9783319596587; 3319596586
• Notes: Note: Includes bibliographical references and index.; Note: Online resource; title from resource home page (SpringerLink, viewed July 17, 2017).
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.